Affinity-based purification of oligonucleotides using soluble mu

Details Affinity-based purification of oligonucleotides using soluble mu Affinity-based purification of oligonucleotides using soluble mu

1996-07-26

1999-06-15

Knode, Marian C.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536 243, 536 245, 536 254, 435 6, C07H 2100, C12Q 168

Patent

active

059123320

ABSTRACT:
The present invention provides novel compounds and methods for purifying oligonucleotides. The compounds according to the invention are multimeric oligonucleotides comprising a multimerization domain for inducing multimeric oligonucleotide aggregation, a hybridization domain that is complementary to a target oligonucleotide whose isolation is desired, and a linker domain connecting the multimerization domain and the hybridization domain. Other compounds of the invention comprise dendrimers having oligonucleotides with hybridization domains linked thereto.
The methods of the invention comprise contacting the compounds of the invention with a solution containing a target oligonucleotide whose purification is desired. The target oligonucleotide hybridizes to the hybridization domain of the inventive compounds, thereby forming an aggregate. Synthetic failure sequences (N-1, N-2, etc.) and other oligonucleotides not complementary to the hybridization domain do not hybridize with the hybridization domain of the compounds and remain free in solution. Conventional size exclusion chromatography or small pore filter membranes are then used to separate the aggregate (and hence target oligonucleotide) from the other oligonucleotides. The aggregate is denatured and the target oligonucleotide separated once again by size exclusion chromatography or with a small pore filter membrane.

REFERENCES:
patent: 5171264 (1992-12-01), Merrill
patent: 5321131 (1994-06-01), Agrawal et al.
patent: 5359047 (1994-10-01), Donahue et al.
patent: 5386020 (1995-01-01), Seeman et al.
patent: 5510471 (1996-04-01), Lebrun et al.
patent: 5536821 (1996-07-01), Agrawal et al.
patent: 5543507 (1996-08-01), Cook et al.
Agrawal and Iyer, Current Opin. Biotech. 6, 12-19 (1995). Month of publication data us unavailable.
Agrawal, Trends in Biotechnol. 10, 152-158 (May, 1992).
Crooke et al., Clin. Pharmacol. Ther. 56, 641-646 (Dec., 1994).
Damha et al., Nucleic Acids Res. 18, 3813-3821 (1990 (Issue No. 13). Month of publication data us unavailable.
Gnanou et al., Makromol. Chem. 189, 2885-2892 (1988). Month of publication data us unavailable.
Habus et al., Bioconjugate Chem. 6, 327-331 (Issue No. 4, Jul./Aug. 1995.
Habus et al., Bioorganic and Med. Chem. Lett. 4, 1065-1068 (1994) (Issue No. 8). Month of publication data us unavailable.
Iversen et al., Antisense Res. Dev. 4, 43-52 (1994). Month of publication data us unavailable.
Newkome et al., Aldrichemica Acta 25, 31-38 (1992) (Issue No. 2). Month of publication data us unavailable.
Nielson et al., J. Mol. Recognition 7, 165-170 (1994). Month of publication data us unavailable.
Padmapriya et al., Antisense Res. Dev. 4, 185-199 (1994). Month of publication data us unavailable.
Rein et al., Acta Polymer 44, 225-229 (1993). Month of publication data us unavailable.
Sen and Gilbert, Nature 334, 364-366 (Jul. 28, 1988).
Uhlmann and Peyman, Chem. Rev. 90, 543-584 (Jun. 1990).
Zhang et al., Clin. Pharmacol. Ther. 58, 44-53 (Issue No. 1, Jul. 1995).
Bianchi et al., "Interaction of a Protein from Rat Liver Nuclei with Cruciform DNA," The EMBO Journal, 7(3), 843-849 (Mar. 1988).
Henderson et al., "Telomere G-Strand Structure and Function Analyzed by Chemical Protection, Base Analogue Substitution, and Utilization by Telomerase in Vitro," Biochemistry, 29(3), 732-737 (Jan. 23, 1990).
Bianchi et al., "Specific Recognition of Cruciform DNA by Nuclear Protein HMG1," Science, 243, 1056-1059 (Feb. 24, 1989).
Bhattacharyya et al., "Model for the Interaction of DNA Junctions and Resolving Enzymes," J. Mol. Biol., 221(4), 1191-1207 (Oct. 20, 1991).
Du et al., "DNA Junctions, Antijunctions, and Mesojunctions," Biochemistry, 31(45), 10955-10963 (Nov. 17, 1992).
Fu et al.(I), "DNA Double-Crossover Molecules," Biochemistry,32(13), 3211-3220 (Apr. 6, 1993).
Chung et al., "Eukaryotic Topoisom erase II Cleavage of Parallel Stranded DNA Tetraplexes," Nucleic Acids Research, 20(8), 1973-1977 (Apr. 25, 1992).
Weisman-Shomer et al., "QUAD, a Protein from Hepatocyte Chromatin That Binds Selectively to Guanine-Rich Quadruplex DNA," J. Biol. Chem., 268(5), 3306-3312 (Feb. 15, 1993).
Goodlett et al., "Direct Observation of a DNA Quadruplex by Electrospray Ionization Mass Spectrometry," Biological Mass Spectrometry, 22, 181-183 (1993).
Rao et al.(I), "Incorporation of 2'-Doexy-6-thioguanosine into G-Rich Oligodeoxyribonucleotides Inhibits G-Tetrad Formation and Facilitates Triplex Formation," Biochemistry, 34(3), 765-772 (Jan. 24, 1995).
Fu et al. (II), "Cleavage of Double-Crossover Molecules by T4 Endonuclease VII," Biochemistry, 33(13), 3896-3905 (Apr. 5, 1994).
Rao et al. (II), "A Total Synthesis of 2'-Deoxy-9-deazaguanosine (9-Deaza-dG) and its Incorporation into Triple Helix Forming Oligodeoxyribonucleotides with Antiparallel Motif," Tetrahedron Letters, 34(42), 6709-6712 (Oct. 15, 1993).
Ecker et al., "Novel Guanosine Quartet Structure Binds to the HIV Envelope and Inhibits Envelope Mediated Cell Fusion," Nucleosides & Nucleotides, 14(3-5), 1117-1127 (May-Jul. 1995).
Jonsson et al., "Role of the His-Cys Finger of Maloney Murine Leukemia Virus Integrase Protein in Integration and Disintegration," J. Virology, 67(9), 5562-5571 (Sep. 1993). GCG).sub.4 ! Isolated From Autoimmune Mice," disclosed at the Symposium of RNA Biology I. RNA-Protein Interactions, Research Triangle Park, NC, Oct. 13-15, 1995, Nucleic Acids Symposium Series, vol. No. 33, 134-136 (1995).
Shida et al., "Interactions Between Quadruple-Stranded Oligodeoxyribonucleotides and Drugs," disclosed at Symposium on Nucleic Acids Technology, Nagoya, Japan, Nov. 8-10, 1990, Nucleic Acids Symposium Series, vol. No. 22, 79-80 (1990).

Affiliated with

Also associated with

Rating

Affinity-based purification of oligonucleotides using soluble mu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Affinity-based purification of oligonucleotides using soluble mu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Affinity-based purification of oligonucleotides using soluble mu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-403357